{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T09:06:07Z","timestamp":1784106367392,"version":"3.55.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:00:00Z","timestamp":1778025600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:00:00Z","timestamp":1778025600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2026,8,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Impact of frailty on prognosis in patients with metastatic and non-metastatic colorectal cancer (CRC) was studied.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Patients aged \u226560 years with CRC were identified in Nationwide Inpatient Sample database and analyzed retrospectively. Frailty was defined when Hospital Frailty Risk Score \u22655. Patients were grouped and matched by metastatic status. Logistic and linear regression were used to assess association between frailty and in-hospital outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>After matching, 99,017 metastatic and 418,435 non-metastatic CRC were included. Frailty was significantly associated with increased in-hospital mortality (metastatic: OR\u2009=\u20091.10, 95% CI 1.05\u20131.17; non-metastatic: aOR\u2009=\u20091.05, 95% CI 1.00\u20131.10), prolonged length of stay (metastatic: OR\u2009=\u20091.30, 95% CI 1.26\u20131.34; non-metastatic: aOR\u2009=\u20091.37, 95% CI 1.34\u20131.39), and discharge to long-term care (metastatic: OR\u2009=\u20091.67, 95% CI 1.62\u20131.73; non-metastatic: aOR\u2009=\u20092.10, 95% CI 2.07\u20132.14). Frailty was also associated with higher total hospital costs, with additional $3,750 (95% CI $2940\u2013$4560) in metastatic CRC and $1920 (95% CI $1480\u2013$2360) in non-metastatic CRC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Frailty is an independent predictor of adverse outcomes among older patients with CRC, regardless of metastatic status.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1038\/s41416-026-03385-2","type":"journal-article","created":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T23:00:31Z","timestamp":1778022031000},"page":"418-426","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The association between hospital frailty risk score and adverse inpatient outcomes in older adults with colorectal cancer"],"prefix":"10.1038","volume":"135","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5936-738X","authenticated-orcid":false,"given":"Hao-Tsai","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0984-8385","authenticated-orcid":false,"given":"Chen-June","family":"Seak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3250-7397","authenticated-orcid":false,"given":"Ching-Yi","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5677-6914","authenticated-orcid":false,"given":"Shu-Wei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4575-2698","authenticated-orcid":false,"given":"Chang-Mu","family":"Sung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6069-1376","authenticated-orcid":false,"given":"Tsung-Hsing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,6]]},"reference":[{"key":"3385_CR1","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.5306\/wjco.v15.i9.1136","volume":"15","author":"H Fadlallah","year":"2024","unstructured":"Fadlallah H, El Masri J, Fakhereddine H, Youssef J, Chemaly C, Doughan S, et al. Colorectal cancer: recent advances in management and treatment. World J Clin Oncol. 2024;15:1136\u201356.","journal-title":"World J Clin Oncol"},{"key":"3385_CR2","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/S2468-1253(21)00368-X","volume":"7","author":"ECH Breekveldt","year":"2022","unstructured":"Breekveldt ECH, Lansdorp-Vogelaar I, Toes-Zoutendijk E, Spaander MCW, Van Vuuren AJ, Van Kemenade FJ, et al. Colorectal cancer incidence, mortality, tumour characteristics, and treatment before and after introduction of the faecal immunochemical testing-based screening programme in the Netherlands: a population-based study. Lancet Gastroenterol Hepatol. 2022;7:60\u20138.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"3385_CR3","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/S0140-6736(19)32319-0","volume":"394","author":"E Dekker","year":"2019","unstructured":"Dekker E, Tanis PJ, Vleugels JLA, Kasi PM, Wallace MB. Colorectal cancer. Lancet. 2019;394:1467\u201380.","journal-title":"Lancet"},{"key":"3385_CR4","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1001\/jama.2021.0106","volume":"325","author":"LH Biller","year":"2021","unstructured":"Biller LH, Schrag D. Diagnosis and treatment of metastatic colorectal cancer. JAMA. 2021;325:669.","journal-title":"JAMA"},{"key":"3385_CR5","first-page":"e113","volume":"21","author":"W Alswealmeen","year":"2022","unstructured":"Alswealmeen W, Sadri L, Perrotti G, Heilman J, Bakshi K, Kim SY, et al. Colorectal cancer screening in the elderly: is age just a number? Clin Colorectal Cancer. 2022;21:e113\u2013e6.","journal-title":"Clin Colorectal Cancer"},{"key":"3385_CR6","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1016\/S0140-6736(19)31786-6","volume":"394","author":"EO Hoogendijk","year":"2019","unstructured":"Hoogendijk EO, Afilalo J, Ensrud KE, Kowal P, Onder G, Fried LP. Frailty: implications for clinical practice and public health. Lancet. 2019;394:1365\u201375.","journal-title":"Lancet"},{"key":"3385_CR7","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.surge.2022.06.001","volume":"21","author":"MG Davey","year":"2023","unstructured":"Davey MG, Joyce WP. Impact of frailty on oncological outcomes in patients undergoing surgery for colorectal cancer \u2013 A systematic review and meta-analysis. Surgeon. 2023;21:173\u201380.","journal-title":"Surgeon"},{"key":"3385_CR8","doi-asserted-by":"crossref","unstructured":"Leng S., Chen X., Mao G. Frailty syndrome: an overview. Clin Interven Aging. 2014;9:433\u201341.","DOI":"10.2147\/CIA.S45300"},{"key":"3385_CR9","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/s43587-020-00017-z","volume":"1","author":"LP Fried","year":"2021","unstructured":"Fried LP, Cohen AA, Xue Q-L, Walston J, Bandeen-Roche K, Varadhan R. The physical frailty syndrome as a transition from homeostatic symphony to cacophony. Nat Aging. 2021;1:36\u201346.","journal-title":"Nat Aging"},{"key":"3385_CR10","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1111\/j.1532-5415.2010.02764.x","volume":"58","author":"X Song","year":"2010","unstructured":"Song X, Mitnitski A, Rockwood K. Prevalence and 10-Year outcomes of frailty in older adults in relation to deficit accumulation. J Am Geriatr Soc. 2010;58:681\u20137.","journal-title":"J Am Geriatr Soc"},{"key":"3385_CR11","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1016\/S0140-6736(18)30668-8","volume":"391","author":"T Gilbert","year":"2018","unstructured":"Gilbert T, Neuburger J, Kraindler J, Keeble E, Smith P, Ariti C, et al. Development and validation of a Hospital Frailty Risk Score focusing on older people in acute care settings using electronic hospital records: an observational study. Lancet. 2018;391:1775\u201382.","journal-title":"Lancet"},{"key":"3385_CR12","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1111\/ggi.14961","volume":"24","author":"J Sinclair De Fr\u00edas","year":"2024","unstructured":"Sinclair De Fr\u00edas J, Olivero L, Gabela A, Jaen D, Menser T, Moreno Franco P. Frailty predicts adverse outcomes in older patients with pulmonary embolism. Geriatr Gerontol Int. 2024;24:924\u20139.","journal-title":"Geriatr Gerontol Int"},{"key":"3385_CR13","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.carrev.2021.02.004","volume":"34","author":"A Abugroun","year":"2022","unstructured":"Abugroun A, Daoud H, Hallak O, Abdel-Rahman ME, Klein LW. Frailty predicts adverse outcomes in older patients undergoing transcatheter aortic valve replacement (TAVR): from the National Inpatient Sample. Cardiovasc Revascularization Med. 2022;34:56\u201360.","journal-title":"Cardiovasc Revascularization Med"},{"key":"3385_CR14","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.amjmed.2022.12.033","volume":"136","author":"E Siddiqui","year":"2023","unstructured":"Siddiqui E, Banco D, Berger JS, Smilowitz NR. Frailty assessment and perioperative major adverse cardiovascular events after noncardiac surgery. Am J Med. 2023;136:372\u20139.e5.","journal-title":"Am J Med"},{"key":"3385_CR15","doi-asserted-by":"publisher","first-page":"2322","DOI":"10.1111\/ans.16941","volume":"91","author":"M Michaud Maturana","year":"2021","unstructured":"Michaud Maturana M, English WJ, Nandakumar M, Li Chen J, Dvorkin L. The impact of frailty on clinical outcomes in colorectal cancer surgery: a systematic literature review. ANZ J Surg. 2021;91:2322\u20139.","journal-title":"ANZ J Surg"},{"key":"3385_CR16","unstructured":"Powell-Cope G., Nelson A. L., Patterson E. S. Advances in patient safety. In: Hughes R. G., editor. Patient safety and quality: an evidence-based handbook for nurses. Rockville (MD): Agency for Healthcare Research and Quality (US); 2008."},{"key":"3385_CR17","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1093\/ageing\/afab073","volume":"50","author":"S Nghiem","year":"2021","unstructured":"Nghiem S, Afoakwah C, Scuffham P, Byrnes J. Hospital frailty risk score and adverse health outcomes: evidence from longitudinal record linkage cardiac data. Age Ageing. 2021;50:1778\u201384.","journal-title":"Age Ageing"},{"key":"3385_CR18","doi-asserted-by":"crossref","unstructured":"Huan-Tze L., Yun-Ru L., Kuan-Der L., Huey-En T. Frailty in chronic myeloid leukemia: evidence from 2016\u20132018 Nationwide Inpatient Sample of the US. BMC Geriatr. 2023;23:334.","DOI":"10.1186\/s12877-023-03962-7"},{"key":"3385_CR19","first-page":"188","volume":"12","author":"WP Glasheen","year":"2019","unstructured":"Glasheen WP, Cordier T, Gumpina R, Haugh GS, Davis J, Renda A. Charlson comorbidity index: ICD-9 Update and ICD-10 translation. Am health drug benefits. 2019;12:188\u201397.","journal-title":"Am health drug benefits"},{"key":"3385_CR20","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.tipsro.2020.09.001","volume":"16","author":"A O\u2019Donovan","year":"2020","unstructured":"O\u2019Donovan A, Leech M. Personalised treatment for older adults with cancer: the role of frailty assessment. Tech Innov Patient Support Radiat Oncol. 2020;16:30\u20138.","journal-title":"Tech Innov Patient Support Radiat Oncol"},{"key":"3385_CR21","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1080\/0284186X.2018.1489144","volume":"57","author":"M \u00d8rum","year":"2018","unstructured":"\u00d8rum M, Gregersen M, Jensen K, Meldgaard P, Damsgaard EMS. Frailty status but not age predicts complications in elderly cancer patients: a follow-up study. Acta Oncol. 2018;57:1458\u201366.","journal-title":"Acta Oncol"},{"key":"3385_CR22","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.ctrv.2018.02.003","volume":"64","author":"D Boakye","year":"2018","unstructured":"Boakye D, Rillmann B, Walter V, Jansen L, Hoffmeister M, Brenner H. Impact of comorbidity and frailty on prognosis in colorectal cancer patients: a systematic review and meta-analysis. Cancer Treat Rev. 2018;64:30\u20139.","journal-title":"Cancer Treat Rev"},{"key":"3385_CR23","doi-asserted-by":"crossref","unstructured":"McGovern J., Dolan RD, Horgan PG, Laird BJ, McMillan DC. The prevalence and prognostic value of frailty screening measures in patients undergoing surgery for colorectal cancer: observations from a systematic review. BMC Geriatr. 2022;22:260.","DOI":"10.1186\/s12877-022-02928-5"},{"key":"3385_CR24","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1080\/08941939.2018.1524528","volume":"33","author":"W Gong","year":"2020","unstructured":"Gong W, Qi X. Association of frailty with delayed recovery of gastrointestinal function after elective colorectal cancer resections. J Investig Surg. 2020;33:544\u201350.","journal-title":"J Investig Surg"},{"key":"3385_CR25","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1016\/S0140-6736(21)01789-X","volume":"398","author":"SG Mohile","year":"2021","unstructured":"Mohile SG, Mohamed MR, Xu H, Culakova E, Loh KP, Magnuson A, et al. Evaluation of geriatric assessment and management on the toxic effects of cancer treatment (GAP70+): a cluster-randomised study. Lancet. 2021;398:1894\u2013904.","journal-title":"Lancet"},{"key":"3385_CR26","doi-asserted-by":"publisher","first-page":"e214158","DOI":"10.1001\/jamaoncol.2021.4158","volume":"7","author":"D Li","year":"2021","unstructured":"Li D, Sun C-L, Kim H, Soto-Perez-De-Celis E, Chung V, Koczywas M, et al. Geriatric Assessment\u2013Driven Intervention (GAIN) on chemotherapy-related toxic effects in older adults with cancer. JAMA Oncol. 2021;7:e214158.","journal-title":"JAMA Oncol"},{"key":"3385_CR27","doi-asserted-by":"publisher","first-page":"e617","DOI":"10.1016\/S2666-7568(22)00169-6","volume":"3","author":"WK Soo","year":"2022","unstructured":"Soo WK, King MT, Pope A, Parente P, D\u0101rzi\u0146\u0161 P, Davis ID. Integrated Geriatric Assessment and Treatment Effectiveness (INTEGERATE) in older people with cancer starting systemic anticancer treatment in Australia: a multicentre, open-label, randomised controlled trial. Lancet Healthy Longev. 2022;3:e617\u2013e27.","journal-title":"Lancet Healthy Longev"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03385-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03385-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03385-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T08:30:51Z","timestamp":1784104251000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03385-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,6]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,8,5]]}},"alternative-id":["3385"],"URL":"https:\/\/doi.org\/10.1038\/s41416-026-03385-2","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,6]]},"assertion":[{"value":"27 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declared no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"All data were obtained through a request to the online HCUP Central Distributor, which manages access to the database (Certificate No. HCUP-28M72GZV7). This study adhered to the NIS Data Use Agreement issued by HCUP. As it involved secondary analysis of de-identified data from the NIS database, neither patients nor the public were directly involved. The study was approved by the Institutional Review Board of Linkou Chang Gung Memorial Hospital (IRB No. 202301018B0), which waived the requirement for signed informed consent due to the use of fully de-identified data.","order":2,"name":"Ethics","label":"Ethics statement","group":{"name":"EthicsHeading","label":"Ethics"}}]}}